PGx Gene testing provides a comprehensive and detailed pharmaceutical report on the most precise and ideal drug and dosage for your unique DNA profile. 

Pharmacogenetic testing (PGx) helps your doctor avoid using a "trial and error approach" when prescribing medications. Modern medications save millions of patient lives a year -- yet,  a prescribed medication may cause severe adverse drug reactions or side effects for YOU, but not for someone else.

"Patients on multiple medications are exposed to far more risks and have a significantly higher probability of experiencing severe side effects from over medication."

Pharmacogenomics examines how YOUR genetic makeup affects your metabolic response to medications. PGx genome testing has been utilized at major medical centers and in the areas of experimental medicine for many years,  but until recently was considered too expensive and specialized to conduct at the clinical level.   PGx testing will become standard procedure for medical providers dispensing pharmaceutical medications and recommended dosages in the near future. 


What are the risk factors associated with adverse drug reactions?

  • The Centers for Disease Control and Prevention (CDC) says that, "Adverse Drug Reactions (ADR's) are a large public health problem".  
  • ADR's cause over 700,000 emergency room visits each year.
  • Elderly people 65 and over are especially vulnerable to drug reactions – and seven times more likely to be hospitalized. 
  • According to the USDA, over 100,000 "preventable" deaths occur each year – in fact, ADR's are now considered the 4th leading cause of death.
  • Patients on multiple medications are exposed to much higher risks of severe or lethal drug reactions as  a result of the  "cocktail effect" from combining medications.


Is PGx testing safe? 

Molecular PGx gene testing is non-invasive and is recommended by the U.S. Food and Drug Administration and the Department of Health and Human Resources. DNA sufficient for testing is gathered by a painless swab of the inside part of your cheek.


Testing is covered by Medicare and most major insurance companies. A co-pay may be required in some cases,  a PGx test can be ordered by a physician as a part of a routine health and wellness exam.  

Simply click the button below to request a PGx test. A lab representative will follow up to schedule a test -- please have the Medicare and Insurance information available. A test may be scheduled at home or at the office of a Physician.  If a test is being requested on behalf of someone else the name and contact information of the representative party may be included in the message box -- along with special instructions. 

aRE PGX TEST RESULTS confidential?

A PGx test may be administered by your personal care physician or in the privacy of your home by a visiting medical professional in conjunction with a routine health and wellness exam. The confidentiality and privacy of the patient's test results are protected by Molecular Testing Labs. MTL will provide the doctor with everything that is required for PGx testing upon request by the patient. 

Molecular Testing Labs™ genetic testing can help to identify YOUR tolerances and metabolic capacity for a comprehensive panel of conditions including pain, psychiatric, cardio and thrombotic medications.  A PGx test report will alert YOU and your physician to crucial life saving data on drugs that could cause adverse or catastrophic reactions to YOU. 

Molecular Testing Labs recommends that you provide copies of your laboratory report to your primary care physician and/or any other specialty physicians who may prescribe medications for you. MTL also provides a "Patient Information Card" that will help in the case of emergency treatment or care from an outside medical practitioner unfamiliar with your medical history. 

Test results are generally available in two weeks and a copy of your PGx report can be forwarded to your personal physician at your request. Note* Physician information may be included in the PGx test request. 


Until recently, most of the data and information available on pharmaceutical genetic testing was research based – including the "Human Genome Project" and extensive studies done by the prestigious Mayo Clinic. In January of 2015, Molecular Testing Labs™ (MTL), received approval for PGx testing services. MTL is CLIA and CAP accredited laboratory that specializes in the cutting edge field of Molecular Genetics. 

 Your doctor may not be aware of the availability of PGx testing -- MTL will provide educational materials and diagnostic information on the benefits of PGx gene testing to your personal care Physician at your request.

How can i find out more ABOUT PGX?

The PGx test request button below may be  used to refer a patient or doctor in need of PGx testing services -- or go to (http://www.yourgenetest.com/).



"A few short years ago, genetic probes were a tool of little more than research labs. Now, with tests for clinically significant and specific gene sequences readily available, they are rapidly becoming the standard of care when using certain drugs and treating specific disorders, A physician who does not take advantage of this once unimaginable technology is only risking patients’ lives and their own medical liability."

“ Molecular testing is transforming the medical practice and is an integral part of personalized medicine and targeted therapy. Molecular testing will be routine clinical tests for the entire spectrum of the disease management."

"At no time in the history of medicine has a technology with such a significant clinical impact moved from the research bench into daily clinical practice. This is only hastened by the FDA warnings being included on increasing numbers of package inserts, just daring physicians to use these medications without genetic testing at their own and the patients’ peril."

"Molecular DNA testing results are the instruction manual that doctors need to properly diagnose and guide their patients treatment."

To find out more about Legacy Care Planning please visit our home page at  www.legacycareplanning.com.  For permissions to publish or reproduce this publication in its entirity or portions therof, please contact the author at: david@legacycareplanning.com